Insider Buying: Susan E. Ball Purchases 1,500 Shares of Cross Country Healthcare Stock (CCRN)
Cross Country Healthcare (NASDAQ:CCRN) General Counsel Susan E. Ball acquired 1,500 shares of the company’s stock on the open market in a transaction that occurred on Friday, June 6th. The shares were purchased at an average cost of $6.72 per share, for a total transaction of $10,080.00. Following the completion of the transaction, the general counsel now directly owns 122,438 shares in the company, valued at approximately $822,783. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Cross Country Healthcare (NASDAQ:CCRN) opened at 6.77 on Tuesday. Cross Country Healthcare has a 52-week low of $4.83 and a 52-week high of $11.54. The stock has a 50-day moving average of $6.26 and a 200-day moving average of $8.37. The company’s market cap is $210.6 million.
Cross Country Healthcare (NASDAQ:CCRN) last posted its quarterly earnings results on Wednesday, May 7th. The company reported ($0.03) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.01) by $0.02. The company had revenue of $118.10 million for the quarter, compared to the consensus estimate of $120.21 million. During the same quarter last year, the company posted ($0.01) earnings per share. Cross Country Healthcare’s revenue was up 7.0% compared to the same quarter last year. Analysts expect that Cross Country Healthcare will post $0.05 EPS for the current fiscal year.
Separately, analysts at Zacks downgraded shares of Cross Country Healthcare from a “neutral” rating to an “underperform” rating in a research note on Monday, May 12th. They now have a $5.40 price target on the stock.
Cross Country Healthcare, Inc (NASDAQ:CCRN) is engaged in the healthcare staffing services business offering a suite staffing and outsourcing services to the healthcare market.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.